Article info

Download PDFPDF
A prospective study of mifepristone and unlimited dosing of sublingual misoprostol for termination of second-trimester pregnancy in Uzbekistan and Ukraine

Authors

  1. Correspondence to Ingrida Platais, Gynuity Health Projects, New York City, NY 10017, USA; iplatais{at}gynuity.org
View Full Text

Citation

Platais I, Tsereteli T, Maystruk G, et al
A prospective study of mifepristone and unlimited dosing of sublingual misoprostol for termination of second-trimester pregnancy in Uzbekistan and Ukraine

Publication history

  • Received June 20, 2018
  • Revised April 16, 2019
  • Accepted May 16, 2019
  • First published June 4, 2019.
Online issue publication 
July 09, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.